tiprankstipranks
Trending News
More News >
Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market

Inhibrx Biosciences Inc (INBX) Income Statement

Compare
53 Followers

Inhibrx Biosciences Inc Income Statement

Last quarter (Q3 2025), Inhibrx Biosciences Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Inhibrx Biosciences Inc's net income was $-35.26M. See Inhibrx Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 200.00K$ 1.80M$ 2.19M$ 7.13M$ 12.81M
Gross Profit
$ -2.08M$ 609.00K$ -107.99M$ 4.44M$ -60.69M
Operating Expenses
$ 329.36M$ 219.83M$ 21.12M$ 12.34M$ 80.25M
Depreciation and Amortization
$ 2.29M$ 1.19M$ 1.23M$ 1.20M$ 1.02M
EBITDA
$ 1.70B$ -206.69M$ -125.82M$ -75.37M$ -63.80M
Operating Income
$ -331.45M$ -219.22M$ -129.12M$ -76.56M$ -67.44M
Other Income/Expenses
$ 2.02B$ -20.50M$ -16.11M$ -5.20M$ -8.19M
Pretax Income
$ 1.69B$ -239.72M$ -145.22M$ -81.77M$ -75.63M
Net Income
$ 1.69B$ -241.36M$ -145.23M$ -81.77M$ -75.64M
Per Share Metrics
Basic EPS
$ 116.58$ -5.12$ -3.62$ -2.15$ -2.99
Diluted EPS
$ 116.58$ -5.12$ -3.62$ -2.15$ -2.99
Weighted Average Shares Outstanding
14.48M 47.13M 40.11M 38.01M 25.26M
Weighted Average Shares Outstanding (Diluted)
14.48M 47.13M 40.11M 38.01M 25.26M
Currency in USD

Inhibrx Biosciences Inc Earnings and Revenue History